Global Dutasteride Soft Capsules Market Growth 2026-2032
The global Dutasteride Soft Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Dutasteride Soft Capsules players cover Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Dutasteride Soft Capsules Industry Forecast” looks at past sales and reviews total world Dutasteride Soft Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Dutasteride Soft Capsules sales for 2026 through 2032. With Dutasteride Soft Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dutasteride Soft Capsules industry.
This Insight Report provides a comprehensive analysis of the global Dutasteride Soft Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dutasteride Soft Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dutasteride Soft Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dutasteride Soft Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dutasteride Soft Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Dutasteride Soft Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Dutasteride Soft Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Dutasteride Soft Capsules players cover Jiangsu Hengrui Pharmaceuticals Co.,ltd., GlaxoSmithKline plc, Sichuan Gowell Pharmaceutical Co., Ltd., Puracap Pharmaceuticals, Qilu Pharmaceutical Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Dutasteride Soft Capsules Industry Forecast” looks at past sales and reviews total world Dutasteride Soft Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Dutasteride Soft Capsules sales for 2026 through 2032. With Dutasteride Soft Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dutasteride Soft Capsules industry.
This Insight Report provides a comprehensive analysis of the global Dutasteride Soft Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dutasteride Soft Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dutasteride Soft Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dutasteride Soft Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dutasteride Soft Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Dutasteride Soft Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Generic Drugs
- Original Drugs
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Hengrui Pharmaceuticals Co.,ltd.
- GlaxoSmithKline plc
- Sichuan Gowell Pharmaceutical Co., Ltd.
- Puracap Pharmaceuticals
- Qilu Pharmaceutical Co., Ltd
- Rivopharm UK Ltd
- DM Pharma Marketing Pvt Ltd
- Mega Lifesciences
- What is the 10-year outlook for the global Dutasteride Soft Capsules market?
- What factors are driving Dutasteride Soft Capsules market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Dutasteride Soft Capsules market opportunities vary by end market size?
- How does Dutasteride Soft Capsules break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dutasteride Soft Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dutasteride Soft Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dutasteride Soft Capsules by Country/Region, 2021, 2025 & 2032
2.2 Dutasteride Soft Capsules Segment by Type
2.2.1 Generic Drugs
2.2.2 Original Drugs
2.2.3 Dutasteride Soft Capsules Sales by Type
2.2.3.1 Global Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Dutasteride Soft Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Dutasteride Soft Capsules Sale Price by Type (2021-2026)
2.3 Dutasteride Soft Capsules Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Dutasteride Soft Capsules Sales by Application
2.3.4.1 Global Dutasteride Soft Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Dutasteride Soft Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Dutasteride Soft Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dutasteride Soft Capsules Breakdown Data by Company
3.1.1 Global Dutasteride Soft Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Dutasteride Soft Capsules Sales Market Share by Company (2021-2026)
3.2 Global Dutasteride Soft Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Dutasteride Soft Capsules Revenue by Company (2021-2026)
3.2.2 Global Dutasteride Soft Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Dutasteride Soft Capsules Sale Price by Company
3.4 Key Manufacturers Dutasteride Soft Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dutasteride Soft Capsules Product Location Distribution
3.4.2 Players Dutasteride Soft Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DUTASTERIDE SOFT CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Dutasteride Soft Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Dutasteride Soft Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dutasteride Soft Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dutasteride Soft Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Dutasteride Soft Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dutasteride Soft Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dutasteride Soft Capsules Sales Growth
4.4 APAC Dutasteride Soft Capsules Sales Growth
4.5 Europe Dutasteride Soft Capsules Sales Growth
4.6 Middle East & Africa Dutasteride Soft Capsules Sales Growth
5 AMERICAS
5.1 Americas Dutasteride Soft Capsules Sales by Country
5.1.1 Americas Dutasteride Soft Capsules Sales by Country (2021-2026)
5.1.2 Americas Dutasteride Soft Capsules Revenue by Country (2021-2026)
5.2 Americas Dutasteride Soft Capsules Sales by Type (2021-2026)
5.3 Americas Dutasteride Soft Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dutasteride Soft Capsules Sales by Region
6.1.1 APAC Dutasteride Soft Capsules Sales by Region (2021-2026)
6.1.2 APAC Dutasteride Soft Capsules Revenue by Region (2021-2026)
6.2 APAC Dutasteride Soft Capsules Sales by Type (2021-2026)
6.3 APAC Dutasteride Soft Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dutasteride Soft Capsules by Country
7.1.1 Europe Dutasteride Soft Capsules Sales by Country (2021-2026)
7.1.2 Europe Dutasteride Soft Capsules Revenue by Country (2021-2026)
7.2 Europe Dutasteride Soft Capsules Sales by Type (2021-2026)
7.3 Europe Dutasteride Soft Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dutasteride Soft Capsules by Country
8.1.1 Middle East & Africa Dutasteride Soft Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dutasteride Soft Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Dutasteride Soft Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Dutasteride Soft Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dutasteride Soft Capsules
10.3 Manufacturing Process Analysis of Dutasteride Soft Capsules
10.4 Industry Chain Structure of Dutasteride Soft Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dutasteride Soft Capsules Distributors
11.3 Dutasteride Soft Capsules Customer
12 WORLD FORECAST REVIEW FOR DUTASTERIDE SOFT CAPSULES BY GEOGRAPHIC REGION
12.1 Global Dutasteride Soft Capsules Market Size Forecast by Region
12.1.1 Global Dutasteride Soft Capsules Forecast by Region (2027-2032)
12.1.2 Global Dutasteride Soft Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dutasteride Soft Capsules Forecast by Type (2027-2032)
12.7 Global Dutasteride Soft Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.1.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.1.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Information
13.2.2 GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolios and Specifications
13.2.3 GlaxoSmithKline plc Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GlaxoSmithKline plc Main Business Overview
13.2.5 GlaxoSmithKline plc Latest Developments
13.3 Sichuan Gowell Pharmaceutical Co., Ltd.
13.3.1 Sichuan Gowell Pharmaceutical Co., Ltd. Company Information
13.3.2 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
13.3.3 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sichuan Gowell Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Sichuan Gowell Pharmaceutical Co., Ltd. Latest Developments
13.4 Puracap Pharmaceuticals
13.4.1 Puracap Pharmaceuticals Company Information
13.4.2 Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolios and Specifications
13.4.3 Puracap Pharmaceuticals Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Puracap Pharmaceuticals Main Business Overview
13.4.5 Puracap Pharmaceuticals Latest Developments
13.5 Qilu Pharmaceutical Co., Ltd
13.5.1 Qilu Pharmaceutical Co., Ltd Company Information
13.5.2 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.5.3 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Qilu Pharmaceutical Co., Ltd Main Business Overview
13.5.5 Qilu Pharmaceutical Co., Ltd Latest Developments
13.6 Rivopharm UK Ltd
13.6.1 Rivopharm UK Ltd Company Information
13.6.2 Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.6.3 Rivopharm UK Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Rivopharm UK Ltd Main Business Overview
13.6.5 Rivopharm UK Ltd Latest Developments
13.7 DM Pharma Marketing Pvt Ltd
13.7.1 DM Pharma Marketing Pvt Ltd Company Information
13.7.2 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.7.3 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 DM Pharma Marketing Pvt Ltd Main Business Overview
13.7.5 DM Pharma Marketing Pvt Ltd Latest Developments
13.8 Mega Lifesciences
13.8.1 Mega Lifesciences Company Information
13.8.2 Mega Lifesciences Dutasteride Soft Capsules Product Portfolios and Specifications
13.8.3 Mega Lifesciences Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mega Lifesciences Main Business Overview
13.8.5 Mega Lifesciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dutasteride Soft Capsules Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dutasteride Soft Capsules by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dutasteride Soft Capsules by Country/Region, 2021, 2025 & 2032
2.2 Dutasteride Soft Capsules Segment by Type
2.2.1 Generic Drugs
2.2.2 Original Drugs
2.2.3 Dutasteride Soft Capsules Sales by Type
2.2.3.1 Global Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
2.2.3.2 Global Dutasteride Soft Capsules Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Dutasteride Soft Capsules Sale Price by Type (2021-2026)
2.3 Dutasteride Soft Capsules Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Dutasteride Soft Capsules Sales by Application
2.3.4.1 Global Dutasteride Soft Capsules Sale Market Share by Application (2021-2026)
2.3.4.2 Global Dutasteride Soft Capsules Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Dutasteride Soft Capsules Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dutasteride Soft Capsules Breakdown Data by Company
3.1.1 Global Dutasteride Soft Capsules Annual Sales by Company (2021-2026)
3.1.2 Global Dutasteride Soft Capsules Sales Market Share by Company (2021-2026)
3.2 Global Dutasteride Soft Capsules Annual Revenue by Company (2021-2026)
3.2.1 Global Dutasteride Soft Capsules Revenue by Company (2021-2026)
3.2.2 Global Dutasteride Soft Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Dutasteride Soft Capsules Sale Price by Company
3.4 Key Manufacturers Dutasteride Soft Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dutasteride Soft Capsules Product Location Distribution
3.4.2 Players Dutasteride Soft Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DUTASTERIDE SOFT CAPSULES BY GEOGRAPHIC REGION
4.1 World Historic Dutasteride Soft Capsules Market Size by Geographic Region (2021-2026)
4.1.1 Global Dutasteride Soft Capsules Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dutasteride Soft Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dutasteride Soft Capsules Market Size by Country/Region (2021-2026)
4.2.1 Global Dutasteride Soft Capsules Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dutasteride Soft Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dutasteride Soft Capsules Sales Growth
4.4 APAC Dutasteride Soft Capsules Sales Growth
4.5 Europe Dutasteride Soft Capsules Sales Growth
4.6 Middle East & Africa Dutasteride Soft Capsules Sales Growth
5 AMERICAS
5.1 Americas Dutasteride Soft Capsules Sales by Country
5.1.1 Americas Dutasteride Soft Capsules Sales by Country (2021-2026)
5.1.2 Americas Dutasteride Soft Capsules Revenue by Country (2021-2026)
5.2 Americas Dutasteride Soft Capsules Sales by Type (2021-2026)
5.3 Americas Dutasteride Soft Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dutasteride Soft Capsules Sales by Region
6.1.1 APAC Dutasteride Soft Capsules Sales by Region (2021-2026)
6.1.2 APAC Dutasteride Soft Capsules Revenue by Region (2021-2026)
6.2 APAC Dutasteride Soft Capsules Sales by Type (2021-2026)
6.3 APAC Dutasteride Soft Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dutasteride Soft Capsules by Country
7.1.1 Europe Dutasteride Soft Capsules Sales by Country (2021-2026)
7.1.2 Europe Dutasteride Soft Capsules Revenue by Country (2021-2026)
7.2 Europe Dutasteride Soft Capsules Sales by Type (2021-2026)
7.3 Europe Dutasteride Soft Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dutasteride Soft Capsules by Country
8.1.1 Middle East & Africa Dutasteride Soft Capsules Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dutasteride Soft Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Dutasteride Soft Capsules Sales by Type (2021-2026)
8.3 Middle East & Africa Dutasteride Soft Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dutasteride Soft Capsules
10.3 Manufacturing Process Analysis of Dutasteride Soft Capsules
10.4 Industry Chain Structure of Dutasteride Soft Capsules
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dutasteride Soft Capsules Distributors
11.3 Dutasteride Soft Capsules Customer
12 WORLD FORECAST REVIEW FOR DUTASTERIDE SOFT CAPSULES BY GEOGRAPHIC REGION
12.1 Global Dutasteride Soft Capsules Market Size Forecast by Region
12.1.1 Global Dutasteride Soft Capsules Forecast by Region (2027-2032)
12.1.2 Global Dutasteride Soft Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dutasteride Soft Capsules Forecast by Type (2027-2032)
12.7 Global Dutasteride Soft Capsules Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.1.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.1.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
13.1.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.1.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.2 GlaxoSmithKline plc
13.2.1 GlaxoSmithKline plc Company Information
13.2.2 GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolios and Specifications
13.2.3 GlaxoSmithKline plc Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GlaxoSmithKline plc Main Business Overview
13.2.5 GlaxoSmithKline plc Latest Developments
13.3 Sichuan Gowell Pharmaceutical Co., Ltd.
13.3.1 Sichuan Gowell Pharmaceutical Co., Ltd. Company Information
13.3.2 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
13.3.3 Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sichuan Gowell Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Sichuan Gowell Pharmaceutical Co., Ltd. Latest Developments
13.4 Puracap Pharmaceuticals
13.4.1 Puracap Pharmaceuticals Company Information
13.4.2 Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolios and Specifications
13.4.3 Puracap Pharmaceuticals Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Puracap Pharmaceuticals Main Business Overview
13.4.5 Puracap Pharmaceuticals Latest Developments
13.5 Qilu Pharmaceutical Co., Ltd
13.5.1 Qilu Pharmaceutical Co., Ltd Company Information
13.5.2 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.5.3 Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Qilu Pharmaceutical Co., Ltd Main Business Overview
13.5.5 Qilu Pharmaceutical Co., Ltd Latest Developments
13.6 Rivopharm UK Ltd
13.6.1 Rivopharm UK Ltd Company Information
13.6.2 Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.6.3 Rivopharm UK Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Rivopharm UK Ltd Main Business Overview
13.6.5 Rivopharm UK Ltd Latest Developments
13.7 DM Pharma Marketing Pvt Ltd
13.7.1 DM Pharma Marketing Pvt Ltd Company Information
13.7.2 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
13.7.3 DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 DM Pharma Marketing Pvt Ltd Main Business Overview
13.7.5 DM Pharma Marketing Pvt Ltd Latest Developments
13.8 Mega Lifesciences
13.8.1 Mega Lifesciences Company Information
13.8.2 Mega Lifesciences Dutasteride Soft Capsules Product Portfolios and Specifications
13.8.3 Mega Lifesciences Dutasteride Soft Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mega Lifesciences Main Business Overview
13.8.5 Mega Lifesciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dutasteride Soft Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dutasteride Soft Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Original Drugs
Table 5. Global Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Dutasteride Soft Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Dutasteride Soft Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Dutasteride Soft Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Dutasteride Soft Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Dutasteride Soft Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Dutasteride Soft Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Dutasteride Soft Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Dutasteride Soft Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Dutasteride Soft Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Dutasteride Soft Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Dutasteride Soft Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Dutasteride Soft Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Dutasteride Soft Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Dutasteride Soft Capsules Producing Area Distribution and Sales Area
Table 21. Players Dutasteride Soft Capsules Products Offered
Table 22. Dutasteride Soft Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dutasteride Soft Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Dutasteride Soft Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Dutasteride Soft Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Dutasteride Soft Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Dutasteride Soft Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Dutasteride Soft Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Dutasteride Soft Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Dutasteride Soft Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Dutasteride Soft Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Dutasteride Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Dutasteride Soft Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Dutasteride Soft Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Dutasteride Soft Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Dutasteride Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Dutasteride Soft Capsules
Table 52. Key Market Challenges & Risks of Dutasteride Soft Capsules
Table 53. Key Industry Trends of Dutasteride Soft Capsules
Table 54. Dutasteride Soft Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dutasteride Soft Capsules Distributors List
Table 57. Dutasteride Soft Capsules Customer List
Table 58. Global Dutasteride Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Dutasteride Soft Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Dutasteride Soft Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Dutasteride Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Dutasteride Soft Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Dutasteride Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Dutasteride Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Dutasteride Soft Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Dutasteride Soft Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Dutasteride Soft Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Dutasteride Soft Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
Table 74. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 76. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 77. GlaxoSmithKline plc Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolios and Specifications
Table 79. GlaxoSmithKline plc Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GlaxoSmithKline plc Main Business
Table 81. GlaxoSmithKline plc Latest Developments
Table 82. Sichuan Gowell Pharmaceutical Co., Ltd. Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
Table 84. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sichuan Gowell Pharmaceutical Co., Ltd. Main Business
Table 86. Sichuan Gowell Pharmaceutical Co., Ltd. Latest Developments
Table 87. Puracap Pharmaceuticals Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolios and Specifications
Table 89. Puracap Pharmaceuticals Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Puracap Pharmaceuticals Main Business
Table 91. Puracap Pharmaceuticals Latest Developments
Table 92. Qilu Pharmaceutical Co., Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 94. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Qilu Pharmaceutical Co., Ltd Main Business
Table 96. Qilu Pharmaceutical Co., Ltd Latest Developments
Table 97. Rivopharm UK Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 99. Rivopharm UK Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Rivopharm UK Ltd Main Business
Table 101. Rivopharm UK Ltd Latest Developments
Table 102. DM Pharma Marketing Pvt Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 104. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. DM Pharma Marketing Pvt Ltd Main Business
Table 106. DM Pharma Marketing Pvt Ltd Latest Developments
Table 107. Mega Lifesciences Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Mega Lifesciences Dutasteride Soft Capsules Product Portfolios and Specifications
Table 109. Mega Lifesciences Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Mega Lifesciences Main Business
Table 111. Mega Lifesciences Latest Developments
Table 1. Dutasteride Soft Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dutasteride Soft Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Original Drugs
Table 5. Global Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 6. Global Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Table 7. Global Dutasteride Soft Capsules Revenue by Type (2021-2026) & ($ million)
Table 8. Global Dutasteride Soft Capsules Revenue Market Share by Type (2021-2026)
Table 9. Global Dutasteride Soft Capsules Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Dutasteride Soft Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Dutasteride Soft Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Dutasteride Soft Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Dutasteride Soft Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Dutasteride Soft Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Dutasteride Soft Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Dutasteride Soft Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Dutasteride Soft Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Dutasteride Soft Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Dutasteride Soft Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Dutasteride Soft Capsules Producing Area Distribution and Sales Area
Table 21. Players Dutasteride Soft Capsules Products Offered
Table 22. Dutasteride Soft Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Dutasteride Soft Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Dutasteride Soft Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Dutasteride Soft Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Dutasteride Soft Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Dutasteride Soft Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Dutasteride Soft Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Dutasteride Soft Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Dutasteride Soft Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Dutasteride Soft Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Dutasteride Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 37. Americas Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Dutasteride Soft Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Dutasteride Soft Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Dutasteride Soft Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 42. APAC Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Dutasteride Soft Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 46. Europe Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Dutasteride Soft Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Dutasteride Soft Capsules Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Dutasteride Soft Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Dutasteride Soft Capsules
Table 52. Key Market Challenges & Risks of Dutasteride Soft Capsules
Table 53. Key Industry Trends of Dutasteride Soft Capsules
Table 54. Dutasteride Soft Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Dutasteride Soft Capsules Distributors List
Table 57. Dutasteride Soft Capsules Customer List
Table 58. Global Dutasteride Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Dutasteride Soft Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Dutasteride Soft Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Dutasteride Soft Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Dutasteride Soft Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Dutasteride Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Dutasteride Soft Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Dutasteride Soft Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Dutasteride Soft Capsules Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Dutasteride Soft Capsules Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Dutasteride Soft Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Dutasteride Soft Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
Table 74. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 76. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 77. GlaxoSmithKline plc Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline plc Dutasteride Soft Capsules Product Portfolios and Specifications
Table 79. GlaxoSmithKline plc Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. GlaxoSmithKline plc Main Business
Table 81. GlaxoSmithKline plc Latest Developments
Table 82. Sichuan Gowell Pharmaceutical Co., Ltd. Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 83. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Product Portfolios and Specifications
Table 84. Sichuan Gowell Pharmaceutical Co., Ltd. Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sichuan Gowell Pharmaceutical Co., Ltd. Main Business
Table 86. Sichuan Gowell Pharmaceutical Co., Ltd. Latest Developments
Table 87. Puracap Pharmaceuticals Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 88. Puracap Pharmaceuticals Dutasteride Soft Capsules Product Portfolios and Specifications
Table 89. Puracap Pharmaceuticals Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Puracap Pharmaceuticals Main Business
Table 91. Puracap Pharmaceuticals Latest Developments
Table 92. Qilu Pharmaceutical Co., Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 93. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 94. Qilu Pharmaceutical Co., Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Qilu Pharmaceutical Co., Ltd Main Business
Table 96. Qilu Pharmaceutical Co., Ltd Latest Developments
Table 97. Rivopharm UK Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 98. Rivopharm UK Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 99. Rivopharm UK Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Rivopharm UK Ltd Main Business
Table 101. Rivopharm UK Ltd Latest Developments
Table 102. DM Pharma Marketing Pvt Ltd Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 103. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Product Portfolios and Specifications
Table 104. DM Pharma Marketing Pvt Ltd Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. DM Pharma Marketing Pvt Ltd Main Business
Table 106. DM Pharma Marketing Pvt Ltd Latest Developments
Table 107. Mega Lifesciences Basic Information, Dutasteride Soft Capsules Manufacturing Base, Sales Area and Its Competitors
Table 108. Mega Lifesciences Dutasteride Soft Capsules Product Portfolios and Specifications
Table 109. Mega Lifesciences Dutasteride Soft Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Mega Lifesciences Main Business
Table 111. Mega Lifesciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dutasteride Soft Capsules
Figure 2. Dutasteride Soft Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dutasteride Soft Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dutasteride Soft Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dutasteride Soft Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dutasteride Soft Capsules Sales Market Share by Country/Region (2025)
Figure 10. Dutasteride Soft Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Generic Drugs
Figure 12. Product Picture of Original Drugs
Figure 13. Global Dutasteride Soft Capsules Sales Market Share by Type in 2026
Figure 14. Global Dutasteride Soft Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Dutasteride Soft Capsules Consumed in Hospital
Figure 16. Global Dutasteride Soft Capsules Market: Hospital (2021-2026) & (K Units)
Figure 17. Dutasteride Soft Capsules Consumed in Clinic
Figure 18. Global Dutasteride Soft Capsules Market: Clinic (2021-2026) & (K Units)
Figure 19. Dutasteride Soft Capsules Consumed in Other
Figure 20. Global Dutasteride Soft Capsules Market: Other (2021-2026) & (K Units)
Figure 21. Global Dutasteride Soft Capsules Sale Market Share by Application (2025)
Figure 22. Global Dutasteride Soft Capsules Revenue Market Share by Application in 2026
Figure 23. Dutasteride Soft Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Dutasteride Soft Capsules Sales Market Share by Company in 2026
Figure 25. Dutasteride Soft Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Dutasteride Soft Capsules Revenue Market Share by Company in 2026
Figure 27. Global Dutasteride Soft Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Dutasteride Soft Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Dutasteride Soft Capsules Sales Market Share by Country in 2026
Figure 38. Americas Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Dutasteride Soft Capsules Sales Market Share by Region in 2026
Figure 46. APAC Dutasteride Soft Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Dutasteride Soft Capsules Sales Market Share by Country in 2026
Figure 57. Europe Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Dutasteride Soft Capsules in 2026
Figure 74. Manufacturing Process Analysis of Dutasteride Soft Capsules
Figure 75. Industry Chain Structure of Dutasteride Soft Capsules
Figure 76. Channels of Distribution
Figure 77. Global Dutasteride Soft Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Dutasteride Soft Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Dutasteride Soft Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Dutasteride Soft Capsules
Figure 2. Dutasteride Soft Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dutasteride Soft Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dutasteride Soft Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dutasteride Soft Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dutasteride Soft Capsules Sales Market Share by Country/Region (2025)
Figure 10. Dutasteride Soft Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Generic Drugs
Figure 12. Product Picture of Original Drugs
Figure 13. Global Dutasteride Soft Capsules Sales Market Share by Type in 2026
Figure 14. Global Dutasteride Soft Capsules Revenue Market Share by Type (2021-2026)
Figure 15. Dutasteride Soft Capsules Consumed in Hospital
Figure 16. Global Dutasteride Soft Capsules Market: Hospital (2021-2026) & (K Units)
Figure 17. Dutasteride Soft Capsules Consumed in Clinic
Figure 18. Global Dutasteride Soft Capsules Market: Clinic (2021-2026) & (K Units)
Figure 19. Dutasteride Soft Capsules Consumed in Other
Figure 20. Global Dutasteride Soft Capsules Market: Other (2021-2026) & (K Units)
Figure 21. Global Dutasteride Soft Capsules Sale Market Share by Application (2025)
Figure 22. Global Dutasteride Soft Capsules Revenue Market Share by Application in 2026
Figure 23. Dutasteride Soft Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Dutasteride Soft Capsules Sales Market Share by Company in 2026
Figure 25. Dutasteride Soft Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Dutasteride Soft Capsules Revenue Market Share by Company in 2026
Figure 27. Global Dutasteride Soft Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Dutasteride Soft Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Dutasteride Soft Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Dutasteride Soft Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Dutasteride Soft Capsules Sales Market Share by Country in 2026
Figure 38. Americas Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 40. Americas Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Dutasteride Soft Capsules Sales Market Share by Region in 2026
Figure 46. APAC Dutasteride Soft Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 48. APAC Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Dutasteride Soft Capsules Sales Market Share by Country in 2026
Figure 57. Europe Dutasteride Soft Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 59. Europe Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Dutasteride Soft Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Dutasteride Soft Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Dutasteride Soft Capsules in 2026
Figure 74. Manufacturing Process Analysis of Dutasteride Soft Capsules
Figure 75. Industry Chain Structure of Dutasteride Soft Capsules
Figure 76. Channels of Distribution
Figure 77. Global Dutasteride Soft Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Dutasteride Soft Capsules Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Dutasteride Soft Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Dutasteride Soft Capsules Revenue Market Share Forecast by Application (2027-2032)
